ellipticine has been researched along with Bladder Cancer in 1 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tao, S | 1 |
| Meng, S | 1 |
| Zheng, X | 1 |
| Xie, L | 1 |
1 other study available for ellipticine and Bladder Cancer
| Article | Year |
|---|---|
ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer.
Topics: Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; CDC2 Protein Kinase; cdc25 Phosphatas | 2017 |